Literature DB >> 7511647

Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. Comparison of its regulatory effect with those of decay accelerating factor and membrane cofactor protein.

K Iwata1, T Seya, H Ariga, S Nagasawa.   

Abstract

C activation on the cell surface is supposedly regulated by membrane cofactor protein (MCP) and decay accelerating factor (DAF). These are complementary in function: MCP acts as a cofactor in factor I-mediated C3b and C4b inactivation, thus preventing the assembly of C3 convertases, whereas DAF accelerates spontaneous decay of the assembled C3 convertase. In this report, a hybrid MCP-DAF was expressed on Chinese hamster ovary cells by transfecting cDNA, and its regulatory activity was compared with those of MCP and DAF transfectants and with a transfectant expressing both MCP and DAF (MCP + DAF). The C3 deposition on sensitized CHO cells through activation of the classical pathway was blocked to a different degree with these transfectants, the order being MCP + DAF > DAF > hybrid MCP-DAF > MCP. Likewise, the C3 deposition via the alternative pathway was blocked efficiently in the order hybrid > MCP + DAF > MCP. The C-mediated cytolysis of CHO cells virtually reflected the degree of C3 fragment deposition. The MCP-DAF transfectant acquired additive protective activity against alternative pathway-mediated C3 deposition and cytolysis but was less potent in circumventing classical pathway attack than cells that expressed DAF alone or DAF + MCP. Hybrid MCP-DAF may be useful for alleviating C-mediated cell damage, especially via the alternative pathway.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7511647

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Molecular remodelling of human CD46 for xenotransplantation: designing a potent complement regulator without measles virus receptor activity.

Authors:  N A Begum; Y Murakami; S Mikata; M Matsumoto; M Hatanaka; S Nagasawa; T Kinoshita; T Seya
Journal:  Immunology       Date:  2000-05       Impact factor: 7.397

2.  Molecular cloning of membrane cofactor protein (MCP; CD46) on B95a cell, an Epstein-Barr virus-transformed marmoset B cell line: B95a-MCP is susceptible to infection by the CAM, but not the Nagahata strain of the measles virus.

Authors:  Y Murakami; T Seya; M Kurita; A Fukui; S Ueda; S Nagasawa
Journal:  Biochem J       Date:  1998-03-15       Impact factor: 3.857

3.  Virus entry is a major determinant of cell tropism of Edmonston and wild-type strains of measles virus as revealed by vesicular stomatitis virus pseudotypes bearing their envelope proteins.

Authors:  H Tatsuo; K Okuma; K Tanaka; N Ono; H Minagawa; A Takade; Y Matsuura; Y Yanagi
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

4.  The F gene of the Osaka-2 strain of measles virus derived from a case of subacute sclerosing panencephalitis is a major determinant of neurovirulence.

Authors:  Minoru Ayata; Kaoru Takeuchi; Makoto Takeda; Shinji Ohgimoto; Seiichi Kato; Luna Bhatta Sharma; Miyuu Tanaka; Mitsuru Kuwamura; Hiroshi Ishida; Hisashi Ogura
Journal:  J Virol       Date:  2010-08-18       Impact factor: 5.103

5.  The CD46 transmembrane domain is required for efficient formation of measles-virus-mediated syncytium.

Authors:  T Seya; M Kurita; K Iwata; Y Yanagi; K Tanaka; K Shida; M Hatanaka; M Matsumoto; S Jun; A Hirano; S Ueda; S Nagasawa
Journal:  Biochem J       Date:  1997-02-15       Impact factor: 3.857

6.  Cell entry by measles virus: long hybrid receptors uncouple binding from membrane fusion.

Authors:  C J Buchholz; U Schneider; P Devaux; D Gerlier; R Cattaneo
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

7.  Modulation of complement regulatory function and measles virus receptor function by the serine-threonine-rich domains of membrane cofactor protein (CD46).

Authors:  K Iwata; T Seya; S Ueda; H Ariga; S Nagasawa
Journal:  Biochem J       Date:  1994-11-15       Impact factor: 3.857

8.  Structure-function analysis of decay-accelerating factor: identification of residues important for binding of the Escherichia coli Dr adhesin and complement regulation.

Authors:  Rafia J Hasan; Edyta Pawelczyk; Petri T Urvil; Mathura S Venkatarajan; Pawel Goluszko; Jozef Kur; Rangaraj Selvarangan; Stella Nowicki; Werner A Braun; Bogdan J Nowicki
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

9.  Blocking measles virus infection with a recombinant soluble form of, or monoclonal antibodies against, membrane cofactor protein of complement (CD46).

Authors:  T Seya; M Kurita; T Hara; K Iwata; T Semba; M Hatanaka; M Matsumoto; Y Yanagi; S Ueda; S Nagasawa
Journal:  Immunology       Date:  1995-04       Impact factor: 7.397

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.